Search Results - "Piruzeli, Maria Lucia B"

Efficacy and safety of baricitinib plus standard of care for the treatment of critically ill hospitalised adults with COVID-19 on invasive mechanical ventilation or extracorporeal membrane oxygenation: an exploratory, randomised, placebo-controlled trial by Ely, E Wesley, Ramanan, Athimalaipet V, Kartman, Cynthia E, de Bono, Stephanie, Liao, Ran, Piruzeli, Maria Lucia B, Goldman, Jason D, Saraiva, José Francisco Kerr, Chakladar, Sujatro, Marconi, Vincent C, Alatorre-Alexander, Jorge, Altclas, Javier David, Casas, Marcelo, CevoliRecio, Valeria, Ellerin, Todd, Giovanni Luz, Kleber, Goldman, Jason D., Juliani Souza Lima, Maria Patelli, Khan, Akram, Paulin, Priscila, Procopio Carvalho, Ana Carolina, Rojas Velasco, Gustavo, Saraiva, Jose Francisco Kerr, Shawa, Imad, Simon Campos, Jesus, Tiffany, Brian, Westheimer Cavalcante, Adilson

“…The oral, selective Janus kinase 1/2 inhibitor baricitinib has shown efficacy in studies of hospitalised adults with COVID-19. COV-BARRIER (NCT04421027) was a…”
Get full text

LB3. Baricitinib plus Standard of Care for Hospitalized Adults with COVID-19 on Invasive Mechanical Ventilation or Extracorporeal Membrane Oxygenation: Results of a Randomized, Placebo-Controlled Trial by Ely, E Wesley, Ramanan, Athimalaipet V, Kartman, Cynthia E, de Bono, Stephanie, Liao, Ran, Piruzeli, Maria Lucia B, Goldman, Jason D, Saraiva, José Francisco Kerr, Chakladar, Sujatro, Marconi, Vincent

“…Abstract Background Interventions to reduce mortality in critically ill patients with COVID-19 are a crucial unmet medical need. Baricitinib (BARI) is an oral,…”
Get full text